Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Certara
Certara
Activities:
Research & Development
Digital
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Regulatory
Certara replaces in-vivo clinical studies for complex generic drug
Virtual bioequivalent was successfully used for FDA abbreviated new drug application (ANDA) approval
Research & Development
Dr William F Feehery is new Certara CEO
Effective 3 June, Dr William F Feehery will take over the model-informed drug development services company
Drug Delivery
Model-informed precision dosing gains scientific support
Certara has published four new papers to provide the necessary evidence to bring model-informed precision dosing to clinics
Research & Development
Certara upgrades drug development Simcyp Simulator
Company launches version 18 of the popular software behind more than 90% FDA-approved drugs
Manufacturing
Certara publishes new report investigating success factors for outcomes-based contracting
Analytica Laser and BaseCase introduce Certara evidence and access solutions for US managed markets
Research & Development
US FDA awards Certara’s Simcyp Division two new dermal virtual bioequivalence grants
New grants support FDA’s GDUFA priorities of expanding bioequivalence methods for topical dermatological products and improving PBPK models of drug absorption via complex delivery routes
Digital
Certara launches BaseCase Portal
The portal will enable life science companies to deliver therapeutic decision-making apps to healthcare professionals at the point of care to individualise patient treatment by making precision-dosing recommendations
Subscribe now